A Phase 1 trial shows a personalized DNA vaccine (GNOS-PV01) is safe and doubles survival rates for aggressive glioblastoma.

Three former European Commissioners warn that scrapping social protections in pursuit of competitiveness will leave the Union ...

Aims To evaluate whether predominantly peripheral lesions (PPLs) and other imaging biomarkers on ultra-widefield (UWF) ...

The new version of the New Jersey Student Learning Assessments — known as the NJSLA — is debuting during a month-long testing ...

BioMedWire Editorial Coverage: For decades, reliably identifying drug and alcohol impairment has been a persistent problem across industries, from traffic enforcement and ...

Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) (“Foremost” or the “Company”) is pleased to announce the successful completion of its ...

The birth of a new General Motors Co. car still begins with a sketch. But after that, the Detroit automaker is leaning into ...

Q1 2026 Earnings Call May 13, 2026 8:00 AM EDTCompany ParticipantsHannes Wittig - Head of Investor RelationsTimotheus Höttges ...

5 Things to Know is CNBC's Morning Squawk newsletter, a before-the-bell briefing on the most important news, trends and analysis that investors need to start their trading day. Subscribe here to ...

Northwestern University engineers have developed a small, wireless polygraph system you can wear. Unlike polygraphs used in ...

Discover 13 top platforms for 2026 to automate your trades, manage risk, and boost efficiency fast on any market now!